Joshua Fitch, Senior Editor

Per CNN, Alito’s order is in effect until May 11, with responses to the case requested by Thursday, May 7.

The court reinstated a nationawide requirement that abortion pills be obtained in person.

During clinical validation done by the company, Unity Confirm demonstrated 100% concordance with known fetal outcomes and invasive diagnostic results in 16 samples.

A study of 1206 women found that while many remain sexually active as they age, a higher number of menopausal symptoms was linked to decreased sexual satisfaction.

Contemporary OB/GYN will be on site in Washington, D.C. to cover the latest data out of the 75th Annual ACOG Clinical & Scientific Meeting.

These are the top 5 headlines you might have missed in April 2026 from Contemporary OB/GYN.

Data presented at HRS 2026 indicates that nearly 60% of arrhythmias in pregnant patients are first detected after the initial 48 hours of cardiac monitoring.

The expanded label to include use during pregnancy complicated by type 1 diabetes mellitus is based on data from the CIRCUIT trial.

"Results remained similar in subgroup analyses of early- and late-onset, and preterm and term preeclampsia," according to findings.

Effective January 1, 2027, the Current Procedural Terminology codes will replace the global maternity payment model to bill for antepartum, labor, delivery, and postpartum phases.

Research presented at SCAI 2026 indicates that although objective illness markers drive treatment, sex differences in clinical communication significantly influence the decision-making process.

Utepreva LLC has launched a proprietary, FDA-cleared endometrial sampler that combines suction, disruption, and absorption to improve tissue yield in 20-second office procedures.

The letter from the federal agency allows further phase 2 development for refisolone under an investigational new drug application.

The incidence of SUI at 6 weeks post partum was 8.7% for the PEFLOW group compared to 13.9% for those receiving usual care (P = .03).

Investigators developed an automated method to categorize maternal morbidity, finding that infection and hypertension account for nearly 45% of nontransfusion-related complications.

ACOG now recommends a combination of transvaginal ultrasonography and endometrial tissue sampling for the initial evaluation of most patients presenting with postmenopausal bleeding.

According to ACOG, approximately 90% of patients diagnosed with endometrial cancer have postmenopausal bleeding. Read more on the College's updated recommendations below.

New research indicates significant disparities in immediate STI antibiotic administration in emergency departments based on pregnancy status.

Routine ultrasound screening at 35 to 37 weeks demonstrates limited accuracy for large-for-gestational age according to new data published in AJOG.

"Given the upper limits of the CI, a relatively higher risk of more than 12% for autism is unlikely to be associated with acetaminophen exposure," the study authors noted.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

While mortality declined by 9.8% in non-ban states, states with abortion bans saw much smaller declines and descriptive increases among non-Hispanic Black and Asian individuals.

New data from JAMA Cardiology indicates that 17.8% of women developed hypertension within 7 years of their first pregnancy, influenced by genetics, BMI, and HDP history.

The FDA cleared the Onclarity HPV Self-Collection Kit, allowing patients to collect samples at home for processing via the FDA-cleared BD Onclarity HPV Assay and BD COR System.

A randomized controlled trial among sexually active premenopausal women found that anterior wall PRP injections vs control led to greater improvement in sexual function.

The Ringza slow-release vaginal ring has launched in Canada and is designed to be re-used for up to 1 year.

PinkDx announced an IJGC publication of data that demonstrated signals associated with endometrial cancer can be detected from a vaginal swab.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Researchers developed a porous membrane organ-on-a-chip that replicates the human cervix to study how the microbiome and immune system interact with chlamydia and gonorrhea.